Modified T Cells Home to Brain Tumors.
In a recent study, researchers investigated why brain cancers are impervious to T cells, and used their findings to create reengineered T cells that are better able to move into tumors. Their "homing system" could improve CAR T-cell therapies for brain cancers, including glioblastoma and medulloblastoma.